CAS: 138926-19-9 - Ibandronate sodium monohydrate

Fórmula: C₉H₂₂NO₇P₂・H₂O・Na

InChI: InChI=1/C9H23NO7P2.Na.H2O/c1-3-4-5-7-10(2)8-6-9(11,18(12,13)14)19(15,16)17;;/h11H,3-8H2,1-2H3,(H2,12,13,14)(H2,15,16,17);;1H2/q;+1;/p-1

Sinónimos:

• [1-Hydroxy-3-(methylpentylamino)-propylidene]bisphosphonic acid sodium salt monohydrate
• Sodium Hydrogen {1-Hydroxy-3-[Methyl(Pentyl)Amino]-1-Phosphonopropyl}Phosphonate Hydrate
• [1-Hydroxy-3-(methylpentylamino)-propylidene]bisphosphonic acid sodium salt

Ibandronate sodium monohydrate CRS

CAS: 138926-19-9

Ibandronate Sodium

CAS: 138926-19-9

Non-halogenated organo-phosphorous derivatives, nesoi

• Fórmula: C₉H₂₂NNaO₇P₂·H₂O
• Forma y color: White Off-White Powder
• Peso molecular: 359.08749

Phosphonic acid, P,P'-[1-hydroxy-3-(methylpentylamino)propylidene]bis-, sodium salt, hydrate (1:1:1)

CAS: 138926-19-9

• Fórmula: C₉H₂₄NNaO₈P₂
• Pureza: ≥98%
• Forma y color: Solid
• Peso molecular: 359.2261

Ibandronate Sodium Monohydrate

CAS: 138926-19-9

• Fórmula: C₉H₂₂NO₇P₂·Na·H₂O
• Forma y color: Neat
• Peso molecular: 359.23

Ibandronate sodium monohydrate

CAS: 138926-19-9

Ibandronate sodium monohydrate (BM-210955) is a highly potent nitrogen-containing bisphosphonate used for the treatment of …

• Fórmula: C₉H₂₅NNaO₈P₂
• Pureza: 99.62%
• Forma y color: White Crystalline Powder
• Peso molecular: 360.23

Ibandronate sodium salt monohydrate

CAS: 138926-19-9

• Fórmula: C₉H₂₂NNaO₇P₂·H₂O
• Pureza: ≤ 0.2%
• Forma y color: White crystalline powder
• Peso molecular: 359.23

Ibandronate Sodium Monohydrate

CAS: 138926-19-9

Applications Inhibits bone resorption as a sodium salt and complexed with technetium Tc 99m for …

• Fórmula: C₉H₂₄NNaO₈P₂
• Forma y color: Neat
• Peso molecular: 359.23

Ibandronate sodium monohydrate

CAS: 138926-19-9

Farnesyl pyrophosphate synthase inhibitor

• Fórmula: C₉H₂₄NNaO₈P₂
• Pureza: Min. 98 Area-%
• Forma y color: Powder
• Peso molecular: 359.23 g/mol

Ibandronate sodium monohydrate - Bio-X ™

CAS: 138926-19-9

Ibandronate is a bisphosphate used in the treatment of osteoporosis in postmenopausal women. This drug …

• Fórmula: C₉H₂₃NO₇P₂•H₂O•Na
• Pureza: Min. 95%
• Forma y color: Powder
• Peso molecular: 360.23 g/mol